Taio Naniwa
Overview
Explore the profile of Taio Naniwa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
335
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kodama A, Tajiri T, Yamabe T, Furukawa Y, Ito Y, Ito K, et al.
Arerugi
. 2024 Sep;
73(8):1000-1005.
PMID: 39261034
There have been no reports of the coexistence of allergic bronchopulmonary aspergillosis (ABPA) and granulomatosis with polyangiitis (GPA). The first case of ABPA with comorbid GPA that developed exophthalmos is...
2.
Uchida H, Nakaoka Y, Sugihara T, Yoshifuji H, Maejima Y, Watanabe Y, et al.
Circ J
. 2024 Sep;
PMID: 39261026
Background: This study aimed to clarify recent clinical features and treatment outcomes in Japanese patients with newly diagnosed Takayasu arteritis (TAK) during the first 2 years of treatment. Methods And...
3.
Miyamae T, Manabe Y, Sugihara T, Umezawa N, Yoshifuji H, Tamura N, et al.
Mod Rheumatol
. 2024 Aug;
35(2):339-344.
PMID: 39116014
Objectives: This study aimed to understand the status quo of medical treatments and pregnancy outcomes in patients with Takayasu arteritis (TAK) and children's birth outcomes. Methods: This study retrospectively enrolled...
4.
Misaki K, Tanaka E, Inoue E, Tamura N, Hirano F, Taniguchi Y, et al.
Mod Rheumatol
. 2024 May;
35(1):17-26.
PMID: 38727535
Objectives: We investigated the long-term effectiveness, safety, and factors affecting Japanese Health Assessment Questionnaire (J-HAQ) improvement during abatacept treatment in Japanese rheumatoid arthritis (RA) patients. Methods: The Orencia® Registry in...
5.
Isogai S, Mizuno M, Uehara K, Okita K, Naniwa T
Int J Rheum Dis
. 2024 Feb;
27(2):e15056.
PMID: 38334164
No abstract available.
6.
Maeda S, Hashimoto H, Maeda T, Tamechika S, Isogai S, Naniwa T, et al.
Lupus Sci Med
. 2023 Oct;
10(2).
PMID: 37802602
Objective: This study sought to elucidate the molecular impacts of belimumab (BEL) treatment on T-cell immune profiling in SLE. Methods: We used mass cytometry with 25 marker panels for T-cell...
7.
Maeda A, Tsuchida N, Uchiyama Y, Horita N, Kobayashi S, Kishimoto M, et al.
Rheumatology (Oxford)
. 2023 Aug;
63(8):2056-2064.
PMID: 37606963
Objectives: To efficiently detect somatic UBA1 variants and establish a clinical scoring system predicting patients with pathogenic variants in VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome. Methods: Eighty-nine Japanese...
8.
Isogai S, Hayashi R, Naniwa T
Intern Med
. 2023 Aug;
63(7):1015-1019.
PMID: 37558480
Mycobacterium chelonae, a rapidly growing mycobacterium found in the natural environment, is known to cause localized lesions in the skin, soft tissue, and bone through traumatic inoculation, but widespread lesions...
9.
Tamechika S, Ohmura S, Maeda S, Naniwa T
J Bone Miner Metab
. 2022 Dec;
41(2):203-211.
PMID: 36512086
Introduction: Evidence on second-line agents for osteoporosis and osteopenia associated with glucocorticoid use after first-line bisphosphonate therapy is limited. We, therefore, examine the efficacy of denosumab on bisphosphonate-treated osteoporosis and...
10.
Sugihara T, Uchida H, Yoshifuji H, Maejima Y, Naniwa T, Katsumata Y, et al.
Mod Rheumatol
. 2022 Oct;
33(6):1145-1153.
PMID: 36218378
Objectives: We aimed to identify associations between patterns of large-vessel lesions of large-vessel giant cell arteritis (LV-GCA) and treatment outcomes. Methods: We extracted data on 68 newly diagnosed patients with...